Skip to main content

People

An Integral Part of the Frederick Community—Michael Dean

For more than 30 years, Michael Dean, Ph.D., has been an integral part of the NCI at Frederick community. In addition to studying several different aspects of genomics and cancer research, he has worked with the Werner H. Kirsten Student Intern Program and also volunteered his time with Mission of Mercy, a community-based organization providing free healthcare and free prescription medications to the uninsured and under-insured.

Craig Reynolds, Ph.D., to Retire as NCI Associate Director for Frederick

On December 2, Craig Reynolds, Ph.D., director, Office of Scientific Operations, and NCI associate director for Frederick, will put the finishing touches on a 37-year career with the National Cancer Institute.

Former WHK Intern Returns to NCI at Frederick as Earl-Stadtman Investigator

The Laboratory of Cell and Developmental Signaling (LCDS) recently welcomed John Brognard, Ph.D., as the new Earl-Stadtman Investigator. While Brognard is new to this role, he is not new to NCI at Frederick. In high school, Brognard was a Werner H. Kirsten Student Intern in what was formerly known as the ABL research program, where he worked under Bob Moschel, Ph.D., senior investigator, and Gary Pauly, Ph.D., currently a staff scientist in the Chemical Biology Laboratory.

A Helping Hand in the Frederick Community—Ross Smith

By day, Ross Smith is the compliance and security officer for Data Management Services, Inc., assigned to the National Cancer Institute (NCI) at Frederick. His role is to ensure the secure operation of in-house computer systems, servers, and network connections. But in his spare time, Smith is also a volunteer firefighter and emergency medical technician (EMT).

In Memoriam: Charles Shive

Earlier this summer, NCI at Frederick lost a friend and colleague, Charles Shive, to cancer. Mr. Shive, better known to most as Charlie, was a systems architect and information technology manager for the Data Science and Information Technology Program, focused on the re-engineering initiative of the Clinical Trials Reporting System.